# China Antihypertensive Trial in Acute Ischemic Stroke II

> **NCT03479554** · PHASE3 · COMPLETED · sponsor: **Tulane University** · enrollment: 4810 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **OTHER:** Early antihypertensive treatment
- **OTHER:** Delayed antihypertensive treatment

## Key facts

- **NCT ID:** NCT03479554
- **Lead sponsor:** Tulane University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-13
- **Primary completion:** 2022-10-15
- **Final completion:** 2023-01-15
- **Target enrollment:** 4810 (ACTUAL)
- **Last updated:** 2023-08-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03479554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03479554, "China Antihypertensive Trial in Acute Ischemic Stroke II". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03479554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*